Breaking News Instant updates and real-time market news.

2022-04-11 16:09:46 ICCC Immucell $8.92 / -0.68 (-7.08%) 16:09 04/11/22 04/11 16:09 04/11/22 16:09	Immucell reports preliminary Q1 revenue $6M vs. $4.1M last year "Sales during the first quarter ended March 31, 2022 increased by 46% to $6.0 million compared to the same period of the prior year, which is exciting for us," commented Michael Brigham, president and CEO of ImmuCell. "This favorable comparison does reflect tighter supply constraints during the first quarter of 2021 before the first level of investments to increase our production capacity had been completed."

2022-04-11 16:09:46

ICCC

Immucell

$8.92 / -0.68 (-7.08%)

16:09

04/11/22

04/11

16:09

04/11/22

16:09

Immucell reports preliminary Q1 revenue $6M vs. $4.1M last year

"Sales during the first quarter ended March 31, 2022 increased by 46% to $6.0 million compared to the same period of the prior year, which is exciting for us," commented Michael Brigham, president and CEO of ImmuCell. "This favorable comparison does reflect tighter supply constraints during the first quarter of 2021 before the first level of investments to increase our production capacity had been completed."

OTHER BREAKING NEWS FROM THE FLY

Recommendations	ams OSRAM price target raised to CHF 7.70 from CHF 7.30 at Credit Suisse » 15:20 02/08/23 02/08 15:20 02/08/23 15:20 AMSSY ams OSRAM $4.05 / -1.005 (-19.88%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research AMSSY ams OSRAM $4.05 / -1.005 (-19.88%) 01/02/23 Energous, ams announce agriculture sensor application collaboration AMSSY ams OSRAM $4.05 / -1.005 (-19.88%) 01/18/23 Bernstein ams OSRAM initiated with a Market Perform at Bernstein 12/06/22 Oddo BHF ams OSRAM downgraded to Underperform from Neutral at Oddo BHF 11/22/22 Credit Suisse ams OSRAM price target lowered to CHF 7.30 from CHF 9.50 at Credit Suisse 11/03/22 Deutsche Bank ams OSRAM price target lowered to CHF 7.50 from CHF 8.50 at Deutsche Bank
Options	Tenet options imply 7.4% move in share price post-earnings » 15:19 02/08/23 02/08 15:19 02/08/23 15:19 THC Tenet Healthcare $54.12 / -0.395 (-0.72%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options THC Tenet Healthcare $54.12 / -0.395 (-0.72%) 01/19/23 Tenet Healthcare CFO Daniel Cancelmi retiring at year-end 01/19/23 Tenet Healthcare now sees 2022 adjusted EBITDA above $3.425B guidance midpoint 01/17/23 Tenet Healthcare up 1% in early trading after Einhorn reveals long position 10/21/22 Tenet Healthcare falls -31.7% THC Tenet Healthcare $54.12 / -0.395 (-0.72%) 01/03/23 Truist Tenet Healthcare price target raised to $60 from $55 at Truist 12/06/22 Loop Capital Tenet Healthcare price target raised to $45 from $40 at Loop Capital 10/27/22 Raymond James Tenet Healthcare price target lowered to $80 from $135 at Raymond James 10/25/22 Citi Tenet Healthcare shares offer 'significant upside,' says Citi THC Tenet Healthcare $54.12 / -0.395 (-0.72%) 10/20/22 Tenet narrows FY22 EPS view to $5.88-$6.42 from $5.80-$7, consensus $6.46 10/20/22 Tenet Healthcare sees Q4 adjusted EPS $1.00-$1.54, consensus $1.80 10/20/22 Tenet Healthcare reports Q3 adjusted EPS $1.44, consensus $1.24 10/20/22 Notable companies reporting after market close THC Tenet Healthcare $54.12 / -0.395 (-0.72%) 01/17/23 Greenlight took 'medium-sized' Tenet Healthcare position in Q4, Bloomberg says THC Tenet Healthcare $54.12 / -0.395 (-0.72%) 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning 10/21/22 What You Missed On Wall Street On Friday 10/21/22 What You Missed On Wall Street This Morning 02/09/23 Tenet Healthcare - THC 02/23/23 Tenet Healthcare THC Tenet Healthcare $54.12 / -0.395 (-0.72%) 01/27/23 Largest borrow rate increases among liquid names 11/21/22 Tenet put volume heavy and directionally bearish 11/09/22 Tenet call volume above normal and directionally bullish 11/08/22 Tenet call volume above normal and directionally bullish
Technical Analysis	NASDAQ market internals summary » 15:17 02/08/23 02/08 15:17 02/08/23 15:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary
Recommendations	BNP Paribas price target raised to EUR 78 from EUR 75 at Credit Suisse » 15:16 02/08/23 02/08 15:16 02/08/23 15:16 BNPQY BNP Paribas $33.59 / +1.09 (+3.35%) Credit Suisse analyst Jon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals BNPQY BNP Paribas $33.59 / +1.09 (+3.35%) 01/17/23 Bank of Montreal gets regulatory approval to acquire Bank of the West 01/03/23 Kentucky lists BlackRock, Citi, JPMorgan as energy boycotters 12/16/22 FDIC identifies deficiencies in Credit Suisse, BNP Paribus 2021 plan submissions 12/08/22 Euronet appoints Torres to board of directors BNPQY BNP Paribas $33.59 / +1.09 (+3.35%) 01/30/23 Barclays Barclays upgrades European banks view to Positive from Neutral 01/13/23 JPMorgan BNP Paribas price target lowered to EUR 60 from EUR 61 at JPMorgan 11/28/22 Barclays BNP Paribas upgraded to Overweight from Equal Weight at Barclays 11/09/22 Morgan Stanley BNP Paribas price target raised to EUR 68 from EUR 67 at Morgan Stanley BNPQY BNP Paribas $33.59 / +1.09 (+3.35%) 11/25/22 Deutsche Bank, BNP to face higher capital requirements from ECB, Bloomberg says 08/25/22 Blackrock, UBS named energy industry boycotters by Texas, WSJ says
Technical Analysis	NYSE market internals summary » 15:16 02/08/23 02/08 15:16 02/08/23 15:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary
Recommendations	Idorsia price target lowered to CHF 12.50 from CHF 15 at Credit Suisse » 15:15 02/08/23 02/08 15:15 02/08/23 15:15 IDRSF Idorsia $13.51 / -1.165 (-7.94%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research IDRSF Idorsia $13.51 / -1.165 (-7.94%) 01/18/23 Jefferies Idorsia downgraded to Hold from Buy at Jefferies 01/03/23 JPMorgan Idorsia price target lowered to CHF 15 from CHF 17 at JPMorgan 11/10/22 Credit Suisse Idorsia downgraded to Neutral from Outperform at Credit Suisse 10/26/22 Credit Suisse Idorsia price target lowered to CHF 21 from CHF 25 at Credit Suisse
Recommendations	TeamViewer price target raised to EUR 15 from EUR 14 at Barclays » 15:12 02/08/23 02/08 15:12 02/08/23 15:12 TMVWY TeamViewer $7.73 / +1.19 (+18.20%) Barclays analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research TMVWY TeamViewer $7.73 / +1.19 (+18.20%) 12/15/22 Manchester United, TeamViewer reach agreement on future partnership 11/30/22 Climb Channel Solutions selects TeamViewer as preferred partner TMVWY TeamViewer $7.73 / +1.19 (+18.20%) 14:31 Today Morgan Stanley TeamViewer price target raised to EUR 13 from EUR 12.50 at Morgan Stanley 02/01/23 JPMorgan TeamViewer downgraded to Underweight from Neutral at JPMorgan 01/12/23 Morgan Stanley TeamViewer price target raised to EUR 12.50 from EUR 12 at Morgan Stanley 12/12/22 Morgan Stanley TeamViewer downgraded to Underweight from Equal Weight at Morgan Stanley
Recommendations	Demant price target raised to DKK 180 from DKK 175 at Barclays » 15:12 02/08/23 02/08 15:12 02/08/23 15:12 WILYY Demant $15.26 / + (+0.00%) Barclays analyst Hassan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research WILYY Demant $15.26 / + (+0.00%) 05:47 Today Danske Bank Demant upgraded to Buy from Hold at Danske Bank 01/30/23 Handelsbanken Demant upgraded to Outperform from Market Perform at Handelsbanken 01/25/23 Exane BNP Paribas Demant downgraded to Neutral from Outperform at Exane BNP Paribas 01/25/23 Jefferies Demant downgraded to Hold from Buy at Jefferies
Options	Lincoln National options imply 7.7% move in share price post-earnings » 15:11 02/08/23 02/08 15:11 02/08/23 15:11 LNC Lincoln National $35.23 / -0.19 (-0.54%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options LNC Lincoln National $35.23 / -0.19 (-0.54%) 12/08/22 Lincoln National falls -7.3% 11/03/22 Lincoln National falls -31.1% 11/03/22 Lincoln National falls -28.3% 11/03/22 Lincoln National falls -25.3% LNC Lincoln National $35.23 / -0.19 (-0.54%) 01/09/23 Barclays Lincoln National cut to Underweight at Barclays amid ongoing capital strain 01/09/23 Barclays Lincoln National downgraded to Underweight from Equal Weight at Barclays 01/06/23 JPMorgan Lincoln National downgraded to Neutral from Overweight at JPMorgan 12/20/22 Piper Sandler Lincoln National price target lowered to $31 from $38 at Piper Sandler LNC Lincoln National $35.23 / -0.19 (-0.54%) 11/02/22 Lincoln National reports Q3 adjusted EPS with items ($10.23), consensus $1.64 LNC Lincoln National $35.23 / -0.19 (-0.54%) 11/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/03/22 What You Missed On Wall Street On Thursday 11/03/22 What You Missed On Wall Street This Morning 02/09/23 Lincoln National - LNC LNC Lincoln National $35.23 / -0.19 (-0.54%) 11/16/22 Early notable gainers among liquid option names on November 16th
Hot Stocks	California AG announces $215M settlement against Centene » 15:09 02/08/23 02/08 15:09 02/08/23 15:09 CNC Centene $73.40 / +2.51 (+3.54%) California Attorney… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CNC Centene $73.40 / +2.51 (+3.54%) 02/02/23 Managed care stocks pressured after CMS' preliminary Medicare Advantage rates 01/23/23 Centene completes divestiture of Magellan Specialty Health to Evolent Health 01/03/23 Centene's Health Net selected for new medi-cal direct contracts 12/16/22 Centene announces $2B increase to stock repurchase program CNC Centene $73.40 / +2.51 (+3.54%) 08:54 Today SVB Securities Cigna price target lowered to $309 from $335 at SVB Securities 07:51 Today Loop Capital Centene price target lowered to $95 from $110 at Loop Capital 05:26 Today Barclays Centene price target lowered to $93 from $100 at Barclays 01/31/23 JPMorgan Medicare Advantage final rule more favorable than feared, says JPMorgan CNC Centene $73.40 / +2.51 (+3.54%) 02/07/23 Centene backs FY23 adjusted EPS view $6.25-$6.40, consensus $6.36 02/07/23 Centene reports Q4 EPS 86c, consensus 85c 02/06/23 Notable companies reporting before tomorrow's open 02/06/23 Notable companies reporting before tomorrow's open CNC Centene $73.40 / +2.51 (+3.54%) 11/29/22 Managed care company returns will be tough to keep replicating, WSJ says 09/23/22 Nebraska picks two current, one new Medicaid health plan provider, OWH reports 09/23/22 UnitedHealth, Molina, Centene win Medicaid contracts in Nebraska, Bloomberg says 08/18/22 White House plans for end of COVID-19 vaccine coverage, WSJ reports CNC Centene $73.40 / +2.51 (+3.54%) 01/03/23 What You Missed On Wall Street On Tuesday 01/03/23 What You Missed On Wall Street This Morning 12/16/22 What You Missed On Wall Street On Friday 12/16/22 What You Missed On Wall Street This Morning 02/28/23 Centene CNC Centene $73.40 / +2.51 (+3.54%) 01/17/23 Centene call volume above normal and directionally bullish 01/09/23 Centene put volume heavy and directionally bearish 12/22/22 Early notable gainers among liquid option names on December 22nd 11/21/22 Centene put volume heavy and directionally bearish

Recommendations	Carlsberg price target raised to DKK 1,269 from DKK 1,162 at Barclays » 15:07 02/08/23 02/08 15:07 02/08/23 15:07 CABGY Carlsberg $27.67 / -0.52 (-1.84%) Barclays analyst Laurence… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CABGY Carlsberg $27.67 / -0.52 (-1.84%) 01/12/23 Deutsche Bank Carlsberg price target lowered to DKK 1,130 from DKK 1,190 at Deutsche Bank 01/09/23 Barclays Carlsberg price target raised to DKK 1,162 from DKK 1,117 at Barclays 12/19/22 Canaccord Waterloo Brewing downgraded to Hold from Buy at Canaccord 11/28/22 JPMorgan Carlsberg downgraded to Underweight from Neutral at JPMorgan
Recommendations	BP price target raised to 1,000 GBp from 700 GBp at Barclays » 15:07 02/08/23 02/08 15:07 02/08/23 15:07 BP BP $38.65 / +0.92 (+2.44%) Barclays analyst Lydia… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BP BP $38.65 / +0.92 (+2.44%) 02/07/23 BP aims for $51B-$56B group EBITDA in 2023 02/07/23 BP sees FY23 CapEx $16B-$18B 01/17/23 Tritium says BP has placed largest order in company history 01/04/23 BP increases investment in onshore U.S. oil and gas to $2.4B in 2023 BP BP $38.65 / +0.92 (+2.44%) 09:18 Today RBC Capital BP price target raised to 650 GBp from 550 GBp at RBC Capital 06:25 Today Bernstein BP price target raised to $53 from $48 at Bernstein 02/07/23 TD Securities BP upgraded to Buy from Hold at TD Securities 01/23/23 Morgan Stanley BP price target raised to 636 GBp from 603 GBp at Morgan Stanley BP BP $38.65 / +0.92 (+2.44%) 02/07/23 BP reports Q4 EPS $1.59, consensus $1.67 11/01/22 BP reports Q3 EPS $2.59, consensus $1.94 BP BP $38.65 / +0.92 (+2.44%) 01/18/23 U.S. Energy Secretary warns GOP of oil bill risks, Reuters says 01/10/23 ExxonMobil led group develops1.3B barrel off shore Guyana field, AP reports 12/05/22 BP bets big on hydrogen as fuel of the future, Reuters reports 12/04/22 OPEC+ keeps oil curbs despite Russia price cap, WSJ reports BP BP $38.65 / +0.92 (+2.44%) 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning 12/05/22 What You Missed On Wall Street On Monday 12/05/22 What You Missed On Wall Street This Morning BP BP $38.65 / +0.92 (+2.44%) 01/20/23 Unusually active option classes on open January 20th 01/09/23 $600k upside call Seller in BP 12/16/22 Unusually active option classes on open December 16th 11/28/22 BP put volume heavy and directionally bearish
Recommendations	Aston Martin Lagonda price target raised to 200 GBp from 175 GBp at Barclays » 15:06 02/08/23 02/08 15:06 02/08/23 15:06 ARGGY Aston Martin Lagonda $2.07 / +0.0296 (+1.45%) Barclays raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ARGGY Aston Martin Lagonda $2.07 / +0.0296 (+1.45%) 01/10/23 Goldman Sachs Aston Martin Lagonda reinstated with a Neutral at Goldman Sachs 11/15/22 Jefferies Aston Martin Lagonda downgraded to Hold from Buy at Jefferies 11/10/22 Barclays Aston Martin Lagonda initiated with an Overweight at Barclays 11/03/22 Deutsche Bank Aston Martin Lagonda price target lowered to 145 GBp at Deutsche Bank
Options	Mattel options imply 6.2% move in share price post-earnings » 15:04 02/08/23 02/08 15:04 02/08/23 15:04 MAT Mattel $20.46 / -0.29 (-1.40%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options MAT Mattel $20.46 / -0.29 (-1.40%) 01/31/23 Mattel, Minecraft announce partnership 01/09/23 Mattel's Fisher-Price re-announces recall of 4.7M Rock 'n Play Sleepers 10/25/22 Mattel says price increase not producing 'meaningful impact on demand' 10/25/22 Mattel says re-evaluating outlook for FY23, expects top and bottom line growth MAT Mattel $20.46 / -0.29 (-1.40%) 01/31/23 Goldman Sachs Mattel assumed with a Buy at Goldman Sachs 10/26/22 DA Davidson Mattel price target lowered to $31 from $45 at DA Davidson 10/13/22 Jefferies Mattel price target lowered to $22, transferred with a Hold at Jefferies 10/05/22 Stifel Hasbro price target lowered to $84 from $99 at Stifel MAT Mattel $20.46 / -0.29 (-1.40%) 12:48 Today Notable companies reporting after market close 10/25/22 Mattel cuts FY22 EPS view to $1.32-$1.42 from $1.42-$1.48 10/25/22 Mattel reports Q3 EPS 82c, consensus 74c 10/25/22 Notable companies reporting after market close MAT Mattel $20.46 / -0.29 (-1.40%) 02/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/25/22 Fly Intel: After-Hours Movers 08/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 17:00 Today Mattel - MAT MAT Mattel $20.46 / -0.29 (-1.40%) 01/09/23 Mattel put volume heavy and directionally bearish 10/25/22 Mattel options imply 7.0% move in share price post-earnings 10/19/22 Mattel call volume above normal and directionally bullish 10/04/22 Mattel Inc call volume above normal and directionally bullish
Recommendations	Zur Rose Group price target raised to CHF 60 from CHF 30 at Berenberg » 15:00 02/08/23 02/08 15:00 02/08/23 15:00 ZRSEF Zur Rose Group $27.06 / + (+0.00%) Berenberg analyst Gerhard… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ZRSEF Zur Rose Group $27.06 / + (+0.00%) 02/07/23 Deutsche Bank Zur Rose Group price target raised to CHF 56 from CHF 22 at Deutsche Bank 02/07/23 UBS Zur Rose Group price target raised to CHF 43 from CHF 23.50 at UBS 02/06/23 Jefferies Zur Rose Group upgraded to Buy from Hold at Jefferies 02/06/23 Deutsche Bank Zur Rose Group upgraded to Hold from Sell at Deutsche Bank
Recommendations	Ubisoft price target lowered to EUR 23 from EUR 42 at Berenberg » 15:00 02/08/23 02/08 15:00 02/08/23 15:00 UBSFY Ubisoft $4.46 / +0.06 (+1.36%) Berenberg analyst Jamie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly UBSFY Ubisoft $4.46 / +0.06 (+1.36%) 01/19/23 Sony announces additional games coming to PlayStation VR2 01/17/23 U.S. video game consumer spending rose 2% y/y in December, says NPD 01/17/23 'Call of Duty: Modern Warfare 2' top game seller in U.S. in December, says NPD 01/11/23 Ubisoft unveils revenue growth measures, cancels three unannounced projects UBSFY Ubisoft $4.46 / +0.06 (+1.36%) 01/31/23 Jefferies Ubisoft assumed with Underperform from Buy at Jefferies 01/19/23 HSBC Ubisoft downgraded to Hold from Buy at HSBC 01/13/23 Barclays Ubisoft price target lowered to EUR 19.50 from EUR 28.50 at Barclays 01/13/23 Deutsche Bank Ubisoft price target lowered to EUR 30 from EUR 40 at Deutsche Bank UBSFY Ubisoft $4.46 / +0.06 (+1.36%) 01/11/23 Ubisoft cuts Q3 net bookings view to EUR725M from EUR830M 01/11/23 Ubisoft cuts FY23 operating income view to (EUR500M) from EUR400M UBSFY Ubisoft $4.46 / +0.06 (+1.36%) 02/06/23 Ubisoft+ on Xbox may be imminent, Windows Central reports 01/18/23 Video game sales fell 13% y/y in Europe in December, GI.biz says 01/18/23 Union calls on Ubisoft workers to strike next week, Kotaku reports 01/11/23 Ubisoft sees FY23 operating income in the red, Bloomberg says UBSFY Ubisoft $4.46 / +0.06 (+1.36%) 02/07/23 What You Missed This Week in Video Games 01/31/23 What You Missed This Week in Video Games 01/24/23 What You Missed This Week in Video Games 01/17/23 What You Missed This Week in Video Games
Recommendations	Stillfront Group price target lowered to SEK 35 from SEK 45 at Berenberg » 14:59 02/08/23 02/08 14:59 02/08/23 14:59 STLFF Stillfront Group $1.77 / + (+0.00%) Berenberg analyst Edward… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research STLFF Stillfront Group $1.77 / + (+0.00%) 01/10/23 Goldman Sachs Stillfront Group downgraded to Neutral from Buy at Goldman Sachs 10/12/22 Kepler Cheuvreux Stillfront Group upgraded to Hold from Reduce at Kepler Cheuvreux 10/11/22 Barclays Stillfront Group price target raised to SEK 31.50 from SEK 30.50 at Barclays 09/16/22 Barclays Stillfront Group price target lowered to SEK 30.50 from SEK 40 at Barclays
Recommendations	Scor price target raised to EUR 29.50 from EUR 28 at Berenberg » 14:59 02/08/23 02/08 14:59 02/08/23 14:59 SCRYY Scor $2.40 / +0.16 (+7.14%) Berenberg analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events SCRYY Scor $2.40 / +0.16 (+7.14%) 01/18/23 JPMorgan Scor price target raised to EUR 18 from EUR 16.50 at JPMorgan 01/13/23 Exane BNP Paribas Scor reinitiated with an Outperform at Exane BNP Paribas 01/10/23 Deutsche Bank Scor price target raised to EUR 27 from EUR 25 at Deutsche Bank 11/22/22 Societe Generale Scor price target lowered to EUR 20 from EUR 21.50 at Societe Generale 03/02/23 Scor - SCRYY
Recommendations	Linea Directa price target lowered to EUR 0.95 from EUR 1.02 at Berenberg » 14:58 02/08/23 02/08 14:58 02/08/23 14:58 LNDAF Linea Directa $1.05 / + (+0.00%) Berenberg analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LNDAF Linea Directa $1.05 / + (+0.00%) 01/05/23 Berenberg Linea Directa downgraded to Hold from Buy at Berenberg 02/23/22 Berenberg Linea Directa price target raised to EUR 2.06 from EUR 2.03 at Berenberg 02/11/22 Berenberg Linea Directa price target raised to EUR 2.03 from EUR 2.01 at Berenberg
Recommendations	Engie SA price target lowered to EUR 15.50 from EUR 16 at Berenberg » 14:58 02/08/23 02/08 14:58 02/08/23 14:58 ENGIY Engie SA $13.76 / -0.2 (-1.43%) Berenberg lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly ENGIY Engie SA $13.76 / -0.2 (-1.43%) 02/02/23 Digital Realty signs power purchase agreement with Engie SA in Germany 09/01/22 Excelerate Energy signs term sheet to deploy FSRU to Germany ENGIY Engie SA $13.76 / -0.2 (-1.43%) 01/17/23 UBS Engie SA price target lowered to EUR 15 from EUR 15.50 at UBS 12/13/22 JPMorgan Engie SA price target lowered to EUR 23 from EUR 24.50 at JPMorgan 11/11/22 Barclays Engie SA price target raised to EUR 18.50 from EUR 18 at Barclays 11/11/22 Deutsche Bank Engie SA price target raised to EUR 16 from EUR 15 at Deutsche Bank ENGIY Engie SA $13.76 / -0.2 (-1.43%) 08/30/22 Gazprom to reduce gas deliveries to France's Engie, Bloomberg reports ENGIY Engie SA $13.76 / -0.2 (-1.43%) 08/30/22 What You Missed On Wall Street On Tuesday 08/30/22 What You Missed On Wall Street This Morning

Recommendations	Embracer Group price target lowered to SEK 110 from SEK 150 at Berenberg » 14:57 02/08/23 02/08 14:57 02/08/23 14:57 THQQF Embracer Group $5.16 / + (+0.00%) Berenberg analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly THQQF Embracer Group $5.16 / + (+0.00%) 02/01/23 'Tomb Raider Reloaded' coming to Google Play, iOS, Netflix on February 14 12/15/22 Amazon confirms deal with Crystal Dynamics to publish new 'Tomb Raider' game 09/20/22 EA's 'Madden NFL 22' best-selling game in U.S. in August, says NPD 08/18/22 Embracer Group to acquire 'Maneater' developer Tripwire THQQF Embracer Group $5.16 / + (+0.00%) 01/31/23 Barclays Embracer Group price target lowered to SEK 46 from SEK 49 at Barclays 01/23/23 Deutsche Bank Embracer Group price target lowered to SEK 60 from SEK 75 at Deutsche Bank 01/10/23 Goldman Sachs Embracer Group price target raised to SEK 58 from SEK 55 at Goldman Sachs 11/18/22 Barclays Embracer Group price target lowered to SEK 49 from SEK 57.20 at Barclays THQQF Embracer Group $5.16 / + (+0.00%) 01/20/23 Crystal Dynamics to accelerate end of 'Avengers' game development, Exputer says 12/15/22 Amazon strikes deal to publish new 'Tomb Raider' game, Verge says 11/01/22 Embracer closes Montreal-based studio Onoma, Bloomberg says 09/21/22 'GTA V' outsells new 'Saints Row' in Europe in August, Gamesindustry.biz says THQQF Embracer Group $5.16 / + (+0.00%) 01/31/23 What You Missed This Week in Video Games 12/20/22 What You Missed This Week in Video Games 09/20/22 What You Missed This Week in Video Games 08/30/22 What You Missed This Week in Video Games
Recommendations	Aedifica price target lowered to EUR 110 from EUR 130 at Berenberg » 14:57 02/08/23 02/08 14:57 02/08/23 14:57 AEDFF Aedifica $92.18 / + (+0.00%) Berenberg analyst Kai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AEDFF Aedifica $92.18 / + (+0.00%) 01/23/23 UBS Aedifica price target lowered to EUR 105 from EUR 115 at UBS 11/24/22 Morgan Stanley Aedifica downgraded to Equal Weight from Overweight at Morgan Stanley 11/23/22 HSBC Aedifica initiated with a Buy at HSBC 07/05/22 Barclays Aedifica price target lowered to EUR 74 from EUR 93 at Barclays
Options	Viking Therapeutics options imply 11.2% move in share price post-earnings » 14:49 02/08/23 02/08 14:49 02/08/23 14:49 VKTX Viking Therapeutics $9.50 / -0.44 (-4.43%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VKTX Viking Therapeutics $9.50 / -0.44 (-4.43%) 01/09/23 Viking Therapeutics completes enrollment in Phase 2b VOYAGE study of VK2809 01/02/23 Ascletis says Viking Therapeutics complaints 'have no merit' 12/19/22 Viking Therapeutics up 58% after Madrigal announces NASH trial data VKTX Viking Therapeutics $9.50 / -0.44 (-4.43%) 01/16/23 Piper Sandler Aligos Therapeutics price target raised to $7 from $3 at Piper Sandler 12/20/22 Maxim Viking Therapeutics price target raised to $15 from $10 at Maxim 12/19/22 Maxim Viking Therapeutics price target raised to $15 from $10 at Maxim 12/19/22 Raymond James Raymond James upgrades Madrigal to Market Perform after NASH data VKTX Viking Therapeutics $9.50 / -0.44 (-4.43%) 10/26/22 Viking Therapeutics reports Q3 EPS (21c), consensus (23c) VKTX Viking Therapeutics $9.50 / -0.44 (-4.43%) 01/02/23 Viking sued Ascletis alleging stolen trade secrets, Reuters reports VKTX Viking Therapeutics $9.50 / -0.44 (-4.43%) 12/21/22 Biotech Alert: Searches spiking for these stocks today 12/19/22 Trial success is rocketing this NASH stock higher and sinking these peers 16:30 Today Viking Therapeutics - VKTX VKTX Viking Therapeutics $9.50 / -0.44 (-4.43%) 01/06/23 Viking Therapeutics call volume above normal and directionally bullish
Hot Stocks	B. Riley Financial exec Moore acquires 20,000 common shares » 14:48 02/08/23 02/08 14:48 02/08/23 14:48 RILY B. Riley Financial $39.53 / -4.59 (-10.40%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly RILY B. Riley Financial $39.53 / -4.59 (-10.40%) 10:08 Today Wolfpack Research short B. Riley Financial, says 'crumbling before our eyes' 10:03 Today B. Riley Financial down 4% after Wolfpack Research issues short report 12/14/22 B. Riley Financial proposes debt restructuring to Core Scientific board 10/19/22 B. Riley Principal Investments acquires Targus for $250M on EV basis RILY B. Riley Financial $39.53 / -4.59 (-10.40%) 03/11/22 Craig-Hallum Lazydays price target lowered to $25 from $33 at Craig-Hallum RILY B. Riley Financial $39.53 / -4.59 (-10.40%) 12/27/22 B. Riley Financial sees FY22 operating adjusted EBTIDA $355M-$365M 12/27/22 B. Riley Financial sees Q4 operating adjusted EBITDA $90M-$100M RILY B. Riley Financial $39.53 / -4.59 (-10.40%) 01/09/23 Fly Insider: Travelzoo, Box among week's notable insider trades 11/03/22 Fly Intel: After-Hours Movers
General news	Fed Governor Waller added to the hawkish rhetoric » 14:45 02/08/23 02/08 14:45 02/08/23 14:45 $ECON Economic Data / + Fed Governor Waller added… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals On The Fly $ECON Economic Data / + $ECON Economic Data / + 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says 01/22/23 Fed sets course for milder interest-rate rise next month, WSJ says 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says $ECON Economic Data / + 02/03/23 What You Missed On Wall Street On Friday 02/01/23 What You Missed On Wall Street On Wednesday 01/24/23 What You Missed On Wall Street On Tuesday 01/18/23 What You Missed On Wall Street On Wednesday

Events

Earnings calls, analyst events, roadshows and more

WYNN
Today at 16:15

Wynn Resorts - WYNN Conference Calls
FORM
Today at 16:25

FormFactor - FORM Conference Calls
DIS
Today at 16:30

Disney - DIS Conference Calls
VKTX
Today at 16:30

Viking Therapeutics - VKTX Conference Calls
AEIS
Today at 16:30

Advanced Energy - AEIS Conference Calls
INFA
Today at 16:30

Informatica - INFA Conference Calls
VNDA
Today at 16:30

Vanda Pharmaceuticals - VNDA Conference Calls
ASGN
Today at 16:30

ASGN - ASGN Conference Calls
RPD
Today at 16:30

Rapid7 - RPD Conference Calls
AZTA
Today at 16:30

Azenta - AZTA Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BLNK X BLNK Blink Charging Spot Secondary Managers: Barclays Priced at: $12.00 8.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	CVAC X CVAC CureVac Secondary Managers: Goldman Sachs, Jefferies, SVB Securities & Kempen Priced at: $9.25 27.027M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DT X DT Dynatrace Spot Secondary Managers: BofA Priced at: $45.55 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan, Goldman Sachs & Morgan Stanley Priced at: $140.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LBPH X LBPH Longboard Pharmaceuticals Spot Secondary Managers: Evercore ISI & Cantor Fitzgerald Priced at: $4.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXST X RXST RxSight Spot Secondary Managers: BofA Priced at: $12.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SINT X SINT Sintx Technologies Spot Secondary Managers: Maxim Priced at: $5.60 2.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STAF X STAF Staffing 360 Solutions Spot Secondary Managers: H.C. Wainwright Priced at: $2.65 1.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMCI X TMCI Treace Medical Spot Secondary Managers: BTIG Priced at: $21.00 4.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XPOF X XPOF Xponential Fitness Spot Secondary Managers: BofA & Jefferies Priced at: $24.50 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	SONN X SONN Sonnet BioTherapeutics Secondary Managers: Chardan & EF Hutton Priced at: $1.08 13.89M Shares
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	BFRG X BFRG Bullfrog AI IPO Managers: WallachBeth, Kingswood $6.50 1.32M Shares HSAI X HSAI Hesai IPO Managers: Goldman Sachs, Morgan Stanley & Credit Suisse, Huatai Securities $17.00 - 19.00 9M Shares INTS X INTS Intensity Therapeutics IPO Managers: Benchmark $4.00-4.50 1.778M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRXS X NRXS Neuraxis IPO Managers: Alexander Capital $7.00-9.00 1.875M Shares NXT X NXT Nextracker IPO Managers: JPMorgan, BofA, Citi & Barclays, Truist, HSBC, BNP Paribas, Mizuho, Scotiabank, KeyBanc $20.00-23.00 23.26M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ENLT X ENLT Enlight Renewable Energy IPO Managers: JPMorgan, BofA & Barclays, Credit Suisse, Wolfe Research, Nomura, HSBC, Roth MKM $20.57 14M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LEWY X LEWY LeeWay Services IPO Managers: ThinkEquity $5.00 1M Shares MLYS X MLYS Mineralys Therapeutics IPO Managers: BofA, Ever Bank, Stifel, Credit Suisse, Guggenheim & Wells Fargo $14.00-16.00 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Immucell reports preliminary Q1 revenue $6M vs. $4.1M last year

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access